Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone

Published:2005-03 Issue:3 Volume:24 Page:190-195
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

V�zquez E.,Mensa J.,Mart�nez J. A.,Marcos M. A.,Puig J.,Ortega M.,Torres A.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-005-1295-9.pdf

Reference26 articles.

1. Barlett JG, Mundy LM (1995) Community-acquired pneumonia. N Engl J Med 333:1618?1624

2. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN (1996) Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 275:134?141

3. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 31:383?421

4. Niederman MS, Mandell LA, Anzueto A, et al (2001) Guidelines for the management of adults with CAP. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 163:1730?1754

5. Macfarlane JT (2001) BTS guidelines for the management of CAP in adults. Thorax 56(Suppl 4):iv1?iv64

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes;The Journal of Infectious Diseases;2024-05-10

2. Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial;Infectious Diseases and Therapy;2021-08-06

3. A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic;Clinical Trials;2021-05-20

4. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review;Current Pediatric Reviews;2021-01-21

5. Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trial;2020-12-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3